Skip to main content
SpringerLink
Log in

Primary Central Nervous System Lymphoma

  • Chapter
Book cover Radiation Oncology

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1946 Accesses

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare type of non-Hodgkin’s lymphoma. Chemotherapy is the mainstay curative treatment for PCNSL. Radiation therapy plays an important role as both an adjuvant treatment and as palliation for patients who are not candidates for curative chemotherapy. The neurotoxicities of combined modality treatment can be severe. The data for treatment of this disease consist of phase II trials and retrospective analyses. The patient populations among these trials are heterogeneous, and comparison between studies is limited. As such, definitive clinical evidence is limited.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abrey LE, Deangelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859–863

    PubMed  CAS  Google Scholar 

  • Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment of primary CNS lymphoma: the next step. J Clin Oncol 18:3144–3150

    PubMed  CAS  Google Scholar 

  • Abrey LE, Batchelor TT, Ferreri MG et al (2005) Report of an international work shop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23:5034–5043

    Article  PubMed  Google Scholar 

  • Braaten KM, Betensky RA, de Leval L et al (2003) BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res 9:1063–1069

    PubMed  CAS  Google Scholar 

  • Bataille B, Delwail V, Menet E et al (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92:261–266

    Article  PubMed  CAS  Google Scholar 

  • Batchelor T, Carson K, O’Neill A et al (2003) Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 21:1044–1049

    Article  PubMed  CAS  Google Scholar 

  • Batchelor TT, Loeffler JS (2006) Primary CNS lymphoma. J Clin Oncol 24:1281–1288

    Article  PubMed  CAS  Google Scholar 

  • Bellinzona M, Roser F, Ostertag H et al (2005) Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases. Eur J Surg Oncol 31:100–105

    Article  PubMed  CAS  Google Scholar 

  • Bessell EM, Graus F, López-Guillermo A et al (2001) CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 50:457–464

    Article  PubMed  CAS  Google Scholar 

  • Bessell EM, López-Guillermo A, Villá S et al (2002) Importance of radiotherapy in outcome of patients with primary CNS lymphoma: An analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. J Clin Oncol 20:231–236

    Article  PubMed  CAS  Google Scholar 

  • Bessell EM, Graus F, Lopez-Guillermo A et al (2004) Primary non-Hodgkin’s lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. Int J Radiat Oncol Biol Phys 59:501–508

    PubMed  Google Scholar 

  • Bessell EM, Hoang-Xuan K, Ferreri AJ et al (2007) Primary central nervous system lymphoma-Biological aspects and controversies in management. Eur J Cancer 43:1141–1152

    Article  PubMed  Google Scholar 

  • Blay JY, Conroy T, Chevreau C et al (1998) High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 16:864–871

    PubMed  CAS  Google Scholar 

  • Corn BW, Dolinskas C, Scott C et al (2000) Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83–15 and 88–06. Int J Radiat Oncol Biol Phys 47:299–303

    Article  PubMed  CAS  Google Scholar 

  • Correa DD, DeAngelis LM, Shi W et al (2004) Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 62:548–555

    PubMed  CAS  Google Scholar 

  • Deangelis LM, Seiferheld W, Schold SC et al. (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 9310. J Clin Oncol 20:4643–4648

    Article  PubMed  Google Scholar 

  • DeAngelis LM (2003) Primary central nervous system lymphoma: a curable brain tumor. J Clin Oncol 21:4471–4473

    Article  PubMed  Google Scholar 

  • Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122

    PubMed  CAS  Google Scholar 

  • Ferreri AJ, Blay JY, Reni M et al (2003) Prognostic scoring system for primary CNS lymphomas: The International Extranodal Lymphoma Study Group experience. J Clin Oncol 21:266–272

    Article  PubMed  Google Scholar 

  • Ferreri AJ, Dell’Oro S, Foppoli M et al (2006) MATILDE regimen followed by radiotherapy is an active strategy against CNS lymphoma. Neurology 66:1435–1438

    Article  PubMed  CAS  Google Scholar 

  • Fine HA (2002) Primary central nervous system lymphoma: time to ask the question. J Clin Oncol 20:4615–4617

    PubMed  Google Scholar 

  • Fisher B, Seiferheld W, Schultz C et al (2005) Secondary analysis of RTOG 9310: an intergroup phase II combined modality treatment of primary CNS lymphoma. J Neurooncol 74:201–205

    Article  PubMed  Google Scholar 

  • Gavrilovi IT, Hormigo A, Yahalom J et al (2006) Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 24:4570–4574

    Article  CAS  Google Scholar 

  • Grimm SA, Yahalom J, Abrey LE et al (2006) Retinopathy in survivors of primary central nervous system lymphoma. Neurology:67:2060–2062

    Article  PubMed  Google Scholar 

  • Harder H, Holtel H, Bromberg JE et al (2004) Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 62:544–547

    PubMed  CAS  Google Scholar 

  • Hottinger AF, DeAngelis LM, Yahalom J et al (2007) Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma. Neurology 69:1178–1182

    Article  PubMed  Google Scholar 

  • Jacomet C, Girard PM, Lebrette MG et al (1997) Intravenous methotrexate for primary central nervous system non-Hodgkin’s lymphoma in AIDS. AIDS 11:1725–1730

    Article  PubMed  CAS  Google Scholar 

  • Jellinger KA, Paulus W (1995) Primary central nervous system lymphomas — New pathological developments. J Neuroncol 24:33–36

    Article  CAS  Google Scholar 

  • Kadan-Lottick NS, Skluzacek MC, Gurney JG (2002) Decreasing incidence rates of primary central nervous system lymphoma. Cancer 95:193–202

    Article  PubMed  Google Scholar 

  • Loeffler JS, Elvin TJ, Mauch P et al (1985) Primary lymphoma of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3:490–494

    PubMed  CAS  Google Scholar 

  • Mead GM, Bleehen NM, Gregor A et al (2000) A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, incristine, and prednisone chemotherapy. Cancer 89:1359–1370

    Article  PubMed  CAS  Google Scholar 

  • Miller DC, Hochberg FH, Harris NL et al (1994) Pathology with clinical correlations of primary central nervous system non-Hodgkin’s lymphoma: The Massachusetts General Hospital experience in 1958–1989. Cancer 74:1383–1397

    Article  PubMed  CAS  Google Scholar 

  • National Comprehensive Cancer Network (2008) Clinical practice guidelines in oncology: Central nervous system cancers. Version I/2008. Available at http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf. Accessed on March 28, 2008

    Google Scholar 

  • Nelson DF, Martz KL, Bonner H et al (1992) Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23:9–17

    PubMed  CAS  Google Scholar 

  • Nguyen PL, Chakravarti A, Finkelstein DM et al (2005) Results of whole brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol 23:1507–1513

    Article  PubMed  Google Scholar 

  • O’Neill BP, Dinapoli RP, Kurtin PJ et al (1995) Occult systemic non-Hodgkin’s lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough? J Neurooncol 25:67–71

    Article  PubMed  CAS  Google Scholar 

  • Omuro AM, DeAngelis LM, Yahalom J et al (2005) Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up. Neurology 64:69–74

    Article  PubMed  CAS  Google Scholar 

  • Pels H, Schmidt-Wolf I, Glasmacher A et al (2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489–4495

    Article  PubMed  CAS  Google Scholar 

  • Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK (2004) Principles and practice of radiation oncology, 4th edn. Lippinicott, Williams, & Wilkins, Philadelphia, pp 2098–2100

    Google Scholar 

  • Poortmans PMP, Kluin-Nelemans C, Haaxama-Reiche H et al (2003) High dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS related primary central nervous system lymphoma; European Organization for research and treatment of cancer lymphoma group phase II trial 20962. J Clin Oncol 21:4483–4488

    Article  PubMed  CAS  Google Scholar 

  • Reni M, Ferreri AJ, Garancini MP et al (1997) Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 8:227–234

    Article  PubMed  CAS  Google Scholar 

  • Reni M, Ferreri AJM, Guha-Thakurta N et al (2001) Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate. Int J Radiat Oncol Biol Phys 51:419–425

    PubMed  CAS  Google Scholar 

  • Schultz C, Scott C, Sherman W et al (1996) Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 14:556–564

    PubMed  CAS  Google Scholar 

  • Shah GD, Yahalom J, Correa DD et al (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25:4730–4735

    Article  PubMed  CAS  Google Scholar 

  • Shibamoto Y, Hayabuchi N, Hiratsuka J et al (2003) Is whole brain irradiation necessary for primary central nervous system lymphoma? Cancer 97:128–133

    Article  PubMed  Google Scholar 

  • Shibamoto Y, Ogino H, Hasegawa M et al (2004) Results of radiation monotherapy for primary central nervous system lymphoma in the 1990’s. Int J Radiat Oncol Biol Phys 62:809–813

    Google Scholar 

  • Silvani A, Salmaggi A, Eoli M et al (2007) Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution. J Neurooncol 82:273–279

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Montefiore Medical Center, 111 East 210th Street, Bronx, NY, 10467, USA

    Evan M. Landau MD & Marnee M. Spierer MD

Authors
  1. Evan M. Landau MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marnee M. Spierer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology National University Cancer Institute of Singapore National University Health System, National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore

    Jiade J. Lu MD, MBA (Associate Professor and Consultant and Distinguished Clinical Professor) (Associate Professor and Consultant and Distinguished Clinical Professor)

  2. Department of Radiation Oncology, Cancer Hospital of Fudan University, 270 Dong An Road, Shanghai, 200232, P.R. China

    Jiade J. Lu MD, MBA (Associate Professor and Consultant and Distinguished Clinical Professor) (Associate Professor and Consultant and Distinguished Clinical Professor)

  3. College of Medicine, Drexel University, Broad & Vine Sts., Mail Stop 200, Philadelphia, PA, 19102-1192, USA

    Luther W. Brady MD (Hylda Cohn/American Cancer Society Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor) (Hylda Cohn/American Cancer Society Professor of Clinical Oncology, and Professor, Department of Radiation Oncology Distinguished University Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Landau, E.M., Spierer, M.M. (2008). Primary Central Nervous System Lymphoma. In: Lu, J.J., Brady, L.W. (eds) Radiation Oncology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77385-6_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-77385-6_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-77384-9

  • Online ISBN: 978-3-540-77385-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation